Cargando…

New Cellular Dimensions on Glioblastoma Progression

Gliomas are brain tumors originated from glial cells. The most frequent form of glioma is the glioblastoma (GB). This lethal tumor is frequently originated from genetic alterations in epidermal growth factor receptor (EGFR) and PI3K pathways. Recent results suggest that signaling pathways, other tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Portela, Marta, Casas-Tintó, Sergio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249559/
https://www.ncbi.nlm.nih.gov/pubmed/32548582
http://dx.doi.org/10.1177/2633105520923076
_version_ 1783538610174164992
author Portela, Marta
Casas-Tintó, Sergio
author_facet Portela, Marta
Casas-Tintó, Sergio
author_sort Portela, Marta
collection PubMed
description Gliomas are brain tumors originated from glial cells. The most frequent form of glioma is the glioblastoma (GB). This lethal tumor is frequently originated from genetic alterations in epidermal growth factor receptor (EGFR) and PI3K pathways. Recent results suggest that signaling pathways, other than primary founder mutations, play a central role in GB progression. Some of these signals are depleted by GB cells from healthy neurons via specialized filopodia known as tumor microtubes (TMs). Here, we discuss the contribution of TMs to vampirize wingless/WNT ligand from neurons. In consequence, wingless/WNT pathway is upregulated in GB to promote tumor progression, and the reduction of these signals in neurons causes the reduction of synapse number and neurodegeneration. These processes contribute to neurological defects and premature death.
format Online
Article
Text
id pubmed-7249559
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-72495592020-06-15 New Cellular Dimensions on Glioblastoma Progression Portela, Marta Casas-Tintó, Sergio Neurosci Insights Commentary Gliomas are brain tumors originated from glial cells. The most frequent form of glioma is the glioblastoma (GB). This lethal tumor is frequently originated from genetic alterations in epidermal growth factor receptor (EGFR) and PI3K pathways. Recent results suggest that signaling pathways, other than primary founder mutations, play a central role in GB progression. Some of these signals are depleted by GB cells from healthy neurons via specialized filopodia known as tumor microtubes (TMs). Here, we discuss the contribution of TMs to vampirize wingless/WNT ligand from neurons. In consequence, wingless/WNT pathway is upregulated in GB to promote tumor progression, and the reduction of these signals in neurons causes the reduction of synapse number and neurodegeneration. These processes contribute to neurological defects and premature death. SAGE Publications 2020-05-22 /pmc/articles/PMC7249559/ /pubmed/32548582 http://dx.doi.org/10.1177/2633105520923076 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Commentary
Portela, Marta
Casas-Tintó, Sergio
New Cellular Dimensions on Glioblastoma Progression
title New Cellular Dimensions on Glioblastoma Progression
title_full New Cellular Dimensions on Glioblastoma Progression
title_fullStr New Cellular Dimensions on Glioblastoma Progression
title_full_unstemmed New Cellular Dimensions on Glioblastoma Progression
title_short New Cellular Dimensions on Glioblastoma Progression
title_sort new cellular dimensions on glioblastoma progression
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249559/
https://www.ncbi.nlm.nih.gov/pubmed/32548582
http://dx.doi.org/10.1177/2633105520923076
work_keys_str_mv AT portelamarta newcellulardimensionsonglioblastomaprogression
AT casastintosergio newcellulardimensionsonglioblastomaprogression